a public good project by the
Synthesis
Company
of California

© 2026

Sanghyun P. Kim | doi.page

0 works0 citations0 h-index

Sanghyun P. Kim

National Institutes of Health(US)National Cancer Institute(US)Center for Cancer Research(US)

Publications by Year

Research Areas

CAR-T cell therapy research, Cancer Immunotherapy and Biomarkers, Virus-based gene therapy research, Immunotherapy and Immune Responses, RNA Research and Splicing

Most-Cited Works

→ Molecular signatures of antitumor neoantigen-reactive T cells from metastatic human cancers(2022)418 cited
→ Mutant U2AF1 Expression Alters Hematopoiesis and Pre-mRNA Splicing In Vivo(2015)280 cited
→ U2AF1 mutations induce oncogenic IRAK4 isoforms and activate innate immune pathways in myeloid malignancies(2019)249 cited
→ Adoptive Cellular Therapy with Autologous Tumor-Infiltrating Lymphocytes and T-cell Receptor–Engineered T Cells Targeting Common p53 Neoantigens in Human Solid Tumors(2022)166 cited
→ U2AF1 mutations alter sequence specificity of pre-mRNA binding and splicing(2014)137 cited
→ Antigen Experienced T Cells from Peripheral Blood Recognize p53 Neoantigens(2020)122 cited

→ Mutant U2AF1-expressing cells are sensitive to pharmacological modulation of the spliceosome(2017)

118 cited

→ Adoptive transfer of personalized neoantigen-reactive TCR-transduced T cells in metastatic colorectal cancer: phase 2 trial interim results(2024)65 cited

→ Identification and Validation of T-cell Receptors Targeting RAS Hotspot Mutations in Human Cancers for Use in Cell-based Immunotherapy(2021)47 cited

→ Transactivation of human immunodeficiency virus type 1 long terminal repeat-directed gene expression by the human foamy virus bel1 protein requires a specific DNA sequence(1992)41 cited